Strong Q3 EPS Performance and Robust 2024 Guidance Justify Buy Rating for UnitedHealth
Barclays Maintains UnitedHealth(UNH.US) With Buy Rating, Maintains Target Price $604
UnitedHealth Group Analyst Ratings
TD Cowen Maintains UnitedHealth(UNH.US) With Buy Rating, Maintains Target Price $601
Barclays Sticks to Their Buy Rating for UnitedHealth (UNH)
UnitedHealth Initiated With an Overweight at KeyBanc
Deutsche Bank Maintains UnitedHealth(UNH.US) With Buy Rating, Maintains Target Price $632
UnitedHealth Group (UNH) Poised for Growth: A Buy Rating With a Favorable 2025 Outlook
Bernstein Maintains UnitedHealth(UNH.US) With Buy Rating, Raises Target Price to $654
Morgan Stanley Maintains UnitedHealth(UNH.US) With Buy Rating, Maintains Target Price $615
UnitedHealth's Strategic Positioning and Resilience Amid MA Challenges: A Buy Rating Analysis
UnitedHealth Group Analyst Ratings
Cantor Fitzgerald Reiterates Overweight on UnitedHealth Group, Maintains $591 Price Target
Wolfe Research Adjusts Price Target on UnitedHealth to $600 From $589
UnitedHealth Group Analyst Ratings
BofA Securities Initiates UnitedHealth(UNH.US) With Buy Rating
Bank of America Securities Reaffirms Their Buy Rating on UnitedHealth (UNH)
UnitedHealth Group Analyst Ratings
Wells Fargo Maintains UnitedHealth(UNH.US) With Buy Rating, Maintains Target Price $630
Wells Fargo Remains a Buy on UnitedHealth (UNH)